Meloxicam Recruiting Phase 2 Trials for Multiple Myeloma (MM) / Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02078102A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma